ANTIPAM INJECTION

Country: Awstralja

Lingwa: Ingliż

Sors: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingredjent attiv:

ATIPAMEZOLE HYDROCHLORIDE

Disponibbli minn:

ZOETIS AUSTRALIA PTY LTD

INN (Isem Internazzjonali):

atipamezole HCl(5mg/mL)

Għamla farmaċewtika:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Kompożizzjoni:

ATIPAMEZOLE HYDROCHLORIDE UNGROUPED Active 5.0 mg/ml

Unitajiet fil-pakkett:

10mL

Klassi:

VM - Veterinary Medicine

Grupp terapewtiku:

CAT | DOG | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | KITTEN | PUPPY

Żona terapewtika:

ANTIDOTES

Indikazzjonijiet terapewtiċi:

MEDETOMIDINE REVERSING AGENT&ANTAGONIST

Sommarju tal-prodott:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; DOG: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; DOG: [MEDETOMIDINE REVERSING AGENT&ANTAGONIST]; For parenteral use in reversing and abolishing the effects of medetomidine hydrochloride in dogs and cats.

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2023-07-01

Fuljett ta 'informazzjoni

Antipam Injection Relevant Label Particulars
02NOV12
[Copy in the header and footer will not appear on the final printed
label}
Vial label main panel
PRESCRIPTION
ANIMAL
REMEDY
KEEP
OUT
OF
REACH
OF
CHILDREN
FOR
ANIMAL
TREATMENT
ONLY
ANTI
PAM
INJECTION
ACTIVE CONSTITUENT:
ATIPAMEZOLE HYDROCHLORIDE 5 mglmL
page 1/5
+
RLP
Approved
FOR
PARENTERAL USE IN REVERSING
AND
ABOLISHING
THE EFFECTS
OF
MEDETOMIDINE
HYDROCHLORIDE
IN
DOGS
AND
CATS
10
mL
[Jurox logo]
Vial label ancillary panel(s)
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE: REFER TO LEAFLET.
Store
below
30°C
(Room Temperature). Do
not
freeze. Protect from light.
APVMA Approval
No:
65929/52317
Jurox Pty Limited
85
Gardiner Street, Rutherford,
NSW
2320,
Australia
lnfoline
1800 023 312
B.
EXP.
JUROX
PTY
LIMITED
Anti pam Injection Relevant Label Particulars
02NOV12
[Copy in the header and footer will not appear on the final printed
label}
Carton
Front
&
Back
Panel
PRESCRIPTION
ANIMAL
REMEDY
KEEP
OUT
OF
REACH
OF
CHILDREN
FOR
ANIMAL
TREATMENT
ONLY
ANTI
PAM
Injection
ACTIVE CONSTITUENT:
ATIPAMEZOLE HYDROCHLORIDE 5
mg/ml
page 2/5
For
parenteral
use
in
reversing
and
abolishing
the
effects
of
medetomidine
hydrochloride
in
dogs
and
cats
[jurox logo]
[10
ml]
Carton:
Side
1
READ
THE
ENCLOSED
LEAFLET
BEFORE
USING
THIS
PRODUCT.
DIRECTIONS
FOR
USE:
Once broached, the product must
be
used within 3 months.
Discard the unused portion.
For parenteral use by intramuscular Injection.
5 times
previous
medetomidine hydrochloride* dose
-400
2.5 times that
of
previous
medetomidine hydrochloride* dose
25-375
Half
of
the volume
medetomidine
hydrochloride* dose
*when formulated at 1
mg
I
mL medetomidine hydrochloride
Jurox
Pry
Limited
Antipam Injection Relevant Label Particulars
02NOV12
page 3/5
[Copy in the header and footer
will
not appear on the final printed label}
Carton:
Side
2
FIRST AID:
If
poisoning
occurs,
contact
a
doctor
or
Poisons
Information
Centre.
Phone Australia 131126.
Dispose
of
empty container by wrapping with paper and placing
in
the garbage.

Karatteristiċi tal-prodott

ANTIPAM INJECTION
Page 1 of 4
continued
ISSUED:
4 MARCH 2014
SAFETY DATA SHEET
SECTION 1: IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY
PRODUCT NAME:
ANTIPAM INJECTION
PRODUCT CODE:
504280 (10 mL)
RECOMMENDED USE:
For parenteral use in reversing and abolishing the effects of
medetomidine
hydrochloride in dogs and cats.
COMPANY IDENTIFICATION:
Jurox Pty Limited
ADDRESS:
85 Gardiner Street
Rutherford NSW 2320
Australia
CUSTOMER CENTRE:
1800 02 3312
NATIONAL POISONS INFORMATION CENTRE:
13 1126 (Australia-wide)
EMERGENCY TELEPHONE NUMBER:
1800 02 3312 (9a.m. – 5p.m.)
SECTION 2: HAZARDS IDENTIFICATION
HAZARD STATUS:
NOT HAZARDOUS ACCORDING TO GHS CRITERIA
RISK PHRASES:
None
SECTION 3: COMPOSITION / INFORMATION ON INGREDIENTS
INGREDIENT
CAS NO.
CONTENT
Atipamezole hydrochloride
104075-48-1
0.5 %
Other ingredients determined to be not hazardous
To 100%
SECTION 4: FIRST AID MEASURES
FIRST AID MEASURES:
Consult the National Poisons Centre on 131126 or a doctor immediately
in every case of
suspected chemical poisoning. Never give fluids or induce vomiting if
a patient is unconscious
or convulsing regardless of cause of injury. If medical
advice/attention is needed, have product
container or label at hand.
INHALATION:
Is unlikely to present an inhalation problem. If respiratory symptoms
do occur, remove patient
to fresh air. Lay patient down and keep warm and rested.
INGESTION:
Is unlikely to present an ingestion hazard. If swallowed, DO NOT
induce vomiting. Rinse
mouth. Keep subject warm and at rest. For advice, contact a doctor or
the National Poisons
Centre on 13 1126.
SKIN:
If skin contact occurs, wash affected area thoroughly with plenty of
soap and water. If skin
irritation or rash occurs, get medical advice.
EYE:
If eye contact occurs, rinse cautiously with water for at least 20
minutes. Continue rinsing.
Ensure complete irrigation of the eye by keeping eyelids apart and
away from eye and moving
the eyelids by occasionally lifting the upper and lower lids. If eye
irritation persists, get medical
advice/attention.

Folja tad-Dejta dwar is-Sigurtà

WWW.JUROX.COM.AU
Customer Service 1800 023 312
® Registered Trademark of Jurox Pty Ltd
TECHNICAL NOTES
ACTIVE CONSTITUENTS
Atipamezole hydrochloride 5 mg/mL
ACTIONS
Atipamezole is a selective alpha-2 adrenergic receptor antagonist.
Atipamezole competitively occupies the alpha-2 receptor,
preventing binding of alpha-2 drugs.
INDICATIONS
Atipamezole is capable of reversing and abolishing the effects of
medetomidine hydrochloride in dogs and cats.
DIRECTIONS FOR USE
Once broached, the product must be used within 3 months. Discard the
unused portion.
For intramuscular injection.
Antipam Injection is quickly absorbed and is generally administered 15
to 60 minutes after medetomidine hydrochloride.
DOSE RATE
For intramuscular injection in dogs and cats.
DOSE (ΜG/KG)
VOLUME
DOGS (I/M INJECTION)
5 times that of previous medetomidine hydrochloride dose
(50 - 400 µg/kg)
The same volume as the medetomidine hydrochloride* dose
CATS (I/M INJECTION)
2.5 times that of previous medetomidine hydrochloride dose
(125 - 375 µg/kg)
Half of the volume of the medetomidine hydrochloride* dose
ANTIPAM
Injection
*when formulated at 1 mg/mL medetomidine hydrochloride
WWW.JUROX.COM.AU
Customer Service 1800 023 312
® Registered Trademark of Jurox Pty Ltd
TECHNICAL NOTES
CONTRAINDICATIONS
Not recommended in pregnant animals due to insufficient data.
WARNINGS AND PRECAUTIONS
Due to the potent pharmacological activity of atipamezole, avoid skin
contact. Wipe off excessive spillage on skin of animals.
SIDE EFFECTS
In dogs, a transient hypotensive effect has been observed during the
first 10 minutes post injection. Vomiting and panting after
atipamezole injection have been reported but these effects appear to
be rare. Transient over-alertness and tachycardia may be
observed after possible overdose.
FIRST AID
If poisoning occurs, contact a doctor or Poisons Information Centre on
13 1126.
DISPOSAL
Dispose of empty container by wrapping with paper and placing in the
garbage.
PRESENTATION
Clear solution
10 mL glass vial
STORAGE
Store below 30°C